Stockscreener 앱 받기
0.74%
시간 외 거래:
전일 마감가:
$285.61
열려 있는:
$285.8
하루 거래량:
1.30M
Relative Volume:
0.56
시가총액:
$154.89B
수익:
$34.76B
순이익/손실:
$6.62B
주가수익비율:
23.52
EPS:
12.23
순현금흐름:
$10.61B
1주 성능:
-2.05%
1개월 성능:
-5.22%
6개월 성능:
-5.92%
1년 성능:
-13.08%
1일 변동 폭
$285.16
$288.30
1주일 범위
$284.87
$294.60
52주 변동 폭
$253.30
$339.17
암젠 Stock (AMGN) Company Profile
명칭
Amgen Inc
전화
(805)447-1000
주소
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
AMGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
287.71 | 153.76B | 34.76B | 6.62B | 10.61B | 12.23 |
|
LLY
Lilly Eli Co
|
732.58 | 656.17B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
177.17 | 422.54B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
210.40 | 367.30B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
126.55 | 244.83B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
84.12 | 207.84B | 63.43B | 16.42B | 14.72B | 6.49 |
암젠 Stock (AMGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-20 | 재개 | Guggenheim | Neutral |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Outperform |
| 2024-10-14 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-05-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 재개 | Raymond James | Mkt Perform |
| 2024-02-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-11-02 | 업그레이드 | Truist | Hold → Buy |
| 2023-10-20 | 재개 | JP Morgan | Neutral |
| 2023-10-17 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 재개 | BofA Securities | Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-04-24 | 재확인 | Oppenheimer | Outperform |
| 2023-03-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 재확인 | Truist | Buy |
| 2022-11-18 | 개시 | Credit Suisse | Underperform |
| 2022-10-31 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-10-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-02-09 | 재확인 | Barclays | Equal Weight |
| 2022-02-09 | 재확인 | Jefferies | Buy |
| 2022-02-09 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 재확인 | Oppenheimer | Outperform |
| 2022-02-09 | 재확인 | Wells Fargo | Equal Weight |
| 2022-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Buy |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-09-23 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 개시 | Daiwa Securities | Buy |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-10-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | 업그레이드 | Truist | Hold → Buy |
| 2020-10-09 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | 다운그레이드 | Truist | Buy → Hold |
| 2020-10-08 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 재개 | Guggenheim | Neutral |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-03-30 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-01-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 개시 | Raymond James | Mkt Perform |
| 2019-12-17 | 재개 | Morgan Stanley | Overweight |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-11-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-19 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-05-23 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
암젠 주식(AMGN)의 최신 뉴스
Epoch Investment Partners Inc. Reduces Stake in Amgen Inc. $AMGN - MarketBeat
Guggenheim Capital LLC Sells 24,052 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Gabelli Funds LLC - MarketBeat
B. Metzler seel. Sohn & Co. AG Has $16.88 Million Holdings in Amgen Inc. $AMGN - MarketBeat
AMGEN to PRESENT at the 2025 WELLS FARGO HEALTHCARE CONFERENCE - MarketScreener
Is Amgen Stock Underperforming The S&P 500? - Barchart.com
Here's Why Amgen (AMGN) is a Strong Value Stock - Yahoo Finance
Baird Financial Group Inc. Decreases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Holdings Boosted by Caisse DE Depot ET Placement DU Quebec - MarketBeat
Canada Pension Plan Investment Board Sells 145,702 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Evergreen Capital Management LLC - MarketBeat
FORA Capital LLC Sells 11,075 Shares of Amgen Inc. $AMGN - MarketBeat
Harvest Portfolios Group Inc. Sells 20,931 Shares of Amgen Inc. $AMGN - MarketBeat
Samalin Investment Counsel LLC Decreases Stock Position in Amgen Inc. $AMGN - MarketBeat
Stock Analysis | Amgen OutlookTechnical Weakness and Mixed Analyst Signals - AInvest
Does Amgen Inc. show high probability of rebound2025 Trading Volume Trends & Safe Entry Trade Reports - Newser
Strategies to average down on Amgen Inc.Profit Target & Fast Gaining Stock Strategy Reports - Newser
What does recent volatility data suggest for Amgen Inc.Earnings Recap Summary & Proven Capital Preservation Methods - Newser
Can momentum traders help lift Amgen Inc.Trade Ideas & Real-Time Price Movement Reports - Newser
Should you hold or exit Amgen Inc. nowMarket Weekly Review & AI Powered Market Entry Ideas - Newser
Reversal indicators forming on Amgen Inc. stock2025 Valuation Update & Stepwise Entry and Exit Trade Signals - Newser
The Manufacturers Life Insurance Company Acquires 600,096 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Position Cut by Smead Capital Management Inc. - MarketBeat
Corebridge Financial Inc. Sells 5,443 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Stock Price Expected to Rise, Piper Sandler Analyst Says - MarketBeat
Zacks Research Analysts Lower Earnings Estimates for Amgen - MarketBeat
Landscape Capital Management L.L.C. Purchases 3,929 Shares of Amgen Inc. $AMGN - MarketBeat
Rafferty Asset Management LLC Cuts Position in Amgen Inc. $AMGN - MarketBeat
Top chart patterns to watch in Amgen Inc.2025 Winners & Losers & AI Driven Stock Reports - Newser
Kayne Anderson Rudnick Investment Management LLC Cuts Stake in Amgen Inc. $AMGN - MarketBeat
Using data models to predict Amgen Inc. stock movementWall Street Watch & High Accuracy Swing Entry Alerts - Newser
Pattern recognition hints at Amgen Inc. upside2025 Earnings Impact & Daily Market Momentum Tracking - Newser
Piper Sandler Lifts PT on Amgen (AMGN) to $342 From $328, Keeps an Overweight Rating - MSN
How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Is Amgen Inc. stock bottoming outLong Setup & Technical Pattern Alert System - Newser
What’s next for Amgen Inc. stock price2025 Volume Leaders & Free High Return Stock Watch Alerts - Newser
With 81% ownership of the shares, Amgen Inc. (NASDAQ:AMGN) is heavily dominated by institutional owners - Yahoo Finance
A Fresh Look at Amgen (AMGN) Valuation After FDA Expands Repatha’s Market Opportunity - simplywall.st
Amgen’s Strategic Position in the Biotech Sector: Pipeline Innovation and Market Leadership - AInvest
Tema Etfs LLC Has $3.03 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Trexquant Investment LP Sells 36,293 Shares of Amgen Inc. $AMGN - MarketBeat
암젠 (AMGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.65%
0.92%
자본화:
|
볼륨(24시간):